Report ID :10079083 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
Global Molecular Diagnostics Industry was valued at USD 24.6 Billion in the year 2019. Global Molecular Diagnostics Industry is further expected to grow at a CAGR of 5.3% from 2019 to reach USD 32.9 Billion by the year 2025. Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Antithrombotic is a medication that keeps the development of thrombus or clump. Antithrombotic and anticoagulant operators are drugs used to decrease the arrangement of blood clusters by lessening the body's ability to shape a blood coagulation. These medications demonstration by keeping the generation of nutrient K in the liver. Antiplatelet, anticoagulant, and thrombolytic operators are distinctive sorts of antithrombotic specialists that demonstration through various thickening procedures. Blood vessel and venous thrombosis, the two sorts of thrombosis, can be treated with antithrombotic drugs.
The three key reasons for thrombosis are hypercoagulability, anomalous stream of blood, and damage caused to endothelial cells of the vein divider. These causes result from hereditary conditions, idleness, smoking, vein harm, pregnancy, and heftiness. As of now, thrombosis and related issue including myocardial dead tissue, stroke, and pneumonic embolism are essentially treated with off-patent anticoagulant drugs viz. warfarin and heparin. The other type of antithrombotic drugs for example headache medicine is additionally off-patent. With a couple of licensed viable fixes accessible in the market, pharmaceutical organizations have sufficient chances to enhance new items. The new medications could be productive for them, as the expanding total populace would guarantee unfaltering increment in the interest for such life-sparing medications. The worldwide antithrombotic/anticoagulant drugs showcase is relied upon to observe high development amid the conjecture time frame, inferable from elements, for example, high accessibility of these medications and ceaseless conditions related with thrombosis that require long haul tranquilize organization.
Major market players in Anticoagulant Drugs Industry are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo, Novartis AG, GlaxoSmithKline plc, Genentech Inc., AstraZeneca plc, Eli Lilly & Company, Aspen Holdings, Portola Pharmaceuticals Inc. and brief information 6 more companies provided in the report.
Anticoagulant Drugs Industry Segmentation:
Anticoagulant Drugs Industry Overview, By Product
• NOACs
• Heparin
• Warfarin
• Others
Anticoagulant Drugs Industry Overview, By Application
• Hospital
• Pharmacy
• Other
Anticoagulant Drugs Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
T
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
